Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
The convergence of antibody engineering, molecular modeling, and receptor biology is reshaping the future of brain-targeted therapeutics
Chemistry & Structural Modification BPC-157 is a linear, non-glycosylated 15-residue peptide with sequence GEPPPGKPADDAGLV (one-letter) or Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Is that the primary use case for this one
In Stock ARA-290 10MG is a 10-milligram format of ARA-290, an erythropoietin derived peptide analogue designed to model tissue protective signaling without erythropoietic activity
Simple Peptide describes GLP-2TZ as "a dual-agonist peptide that activates the GLP-1 and GIP receptors to show how these signals influence insulin, fat use, and energy levels." If you are familiar with tirzepatide dose charts and standard research protocols, the underlying compound is identical
US$ 27.97
US$ 23.39
US$ 27.58
US$ 20.01
US$ 24.55
US$ 23.07
US$ 29.20
US$ 20.21
US$ 25.77
US$ 26.05